146 related articles for article (PubMed ID: 22122746)
1. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation markers for early detection of women's cancer: promise and challenges.
Wittenberger T; Sleigh S; Reisel D; Zikan M; Wahl B; Alunni-Fabbroni M; Jones A; Evans I; Koch J; Paprotka T; Lempiäinen H; Rujan T; Rack B; Cibula D; Widschwendter M
Epigenomics; 2014 Jun; 6(3):311-27. PubMed ID: 25111485
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of epigenetics in urological cancers.
Ramachandran K; Soloway MS; Singal R; Manoharan M
Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.
Claus R; Plass C; Armstrong SA; Bullinger L
Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Zhou XC; Dowdy SC; Podratz KC; Jiang SW
Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
[TBL] [Abstract][Full Text] [Related]
7. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
8. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
Koturbash I; Beland FA; Pogribny IP
Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA methylation for cancer detection: promises and challenges.
Zhu J; Yao X
Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
[TBL] [Abstract][Full Text] [Related]
10. The developing female genital tract: from genetics to epigenetics.
Massé J; Watrin T; Laurent A; Deschamps S; Guerrier D; Pellerin I
Int J Dev Biol; 2009; 53(2-3):411-24. PubMed ID: 19412895
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic applications of epigenetics.
Miyamoto K; Ushijima T
Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in virus-associated human cancers.
Li HP; Leu YW; Chang YS
Cell Res; 2005 Apr; 15(4):262-71. PubMed ID: 15857581
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
16. The role of epigenetic alterations in pancreatic cancer.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
19. Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers.
Lee YC; Wang HP; Wang CP; Ko JY; Lee JM; Chiu HM; Lin JT; Yamashita S; Oka D; Watanabe N; Matsuda Y; Ushijima T; Wu MS
Cancer Prev Res (Phila); 2011 Dec; 4(12):1982-92. PubMed ID: 21952583
[TBL] [Abstract][Full Text] [Related]
20. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]